Company / EPS (Diluted)
Centessa Pharmaceuticals plc EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.46
FY2025
5-year range
-$5.07 / -$1.46
FY2021-FY2025
Trend
+29.1%
vs FY2024
Sector context
#109 of 204
Health Care
What the data says
At $-1.46, Centessa Pharmaceuticals plc's eps (diluted) ranks #109 of 204 in the Health Care sector. Improved from $-2.31 to $-1.46 over the past 2 years.
Based on SEC 10-K filings.
-1.46 in FY2025.
Improved from $-2.31 to $-1.46 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#109 of 204 in Health CareTop 53% of 204This company -$1.46 Sector average -$1.30
▼
-12.0% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 29.1% year-over-year.
- Ranks #109 out of 204 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.46 | +29.1% |
| FY2024 | -$2.06 | +10.8% |
| FY2023 | -$2.31 | +0.0% |
| FY2022 | -$2.31 | +54.4% |
| FY2021 | -$5.07 | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026